Search all trials

Find therapies in clinical trials near you

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Metabolic dysfunction-associated steatohepatitis+1

Recruiting

Investigational

A Phase III Study of Survodutide in Adults with Compensated NASH Cirrhosis to Assess Liver Outcomes and Safety

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:BI 456906

Contact Research Centre

Metabolic dysfunction-associated steatohepatitis+1

Recruiting

Investigational

A Phase III trial of BI 456906 weekly injections in adults with NASH and stage 2‑3 liver fibrosis

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:BI 456906

Contact Research Centre

Metabolic dysfunction-associated liver disease

Recruiting

Investigational

Study on the Effects of Pegozafermin for Patients with Nonalcoholic Steatohepatitis (NASH) and Fibrosis

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Bio89-100

Contact Research Centre

Hepatic cirrhosis

Recruiting

Investigational

Study of Pegozafermin Treatment for Patients with Liver Cirrhosis due to Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Bio89-100

Contact Research Centre

Cholangitis sclerosing

Recruiting

Investigational

A Phase III Study of Elafibranor in Adults with Primary Sclerosing Cholangitis to Assess Efficacy and Safety

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Elafibranor

Contact Research Centre

Metabolic dysfunction-associated steatohepatitis

Recruiting

Investigational

A Phase 3 Study of Efimosfermin Alfa to Assess Safety and Tolerability in Adults with F2‑F3 Stage Metabolic Dysfunction‑Associated Steatohepatitis (MASH)

Investigational

Poland

Participants:18–64 years · 65+ years

Contact Research Centre

Metabolic dysfunction-associated steatohepatitis

Recruiting

Investigational

Safety and Efficacy of Efimosfermin Alfa in Participants with Biopsy‑Confirmed F2‑ or F3‑Stage Metabolic Dysfunction‑Associated Steatohepatitis (MASH)

Investigational

Poland

Participants:18–64 years · 65+ years

Contact Research Centre

Metabolic dysfunction-associated liver disease

Recruiting

Investigational

N1T-MC-MALO: A Master Protocol for a Randomized, Controlled, Clinical Trial of Multiple Pharmacologic Agents in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease Who Are at Increased Risk of Developing Major Adverse Liver Outcomes (SYNERGY-Outcomes); N1T-MC-TZ01 Tirzepatide in participants with high-risk MASLD; N1T-MC-RT01 Retatrutide in participants with high-risk MASLD

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Ly3437943 Sodium

Contact Research Centre

Prostate cancer

Recruiting

Registered drugNo placebo

A study testing ASP5541 compared to abiraterone acetate in patients with advanced prostate cancer

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Abiraterone Acetate

Contact Research Centre

Primary biliary cholangitis

Recruiting

Investigational

Study of Seladelpar Treatment in Patients with Primary Biliary Cholangitis and Compensated Cirrhosis

Investigational

Poland

Participants:18–64 years · 65+ years
Substances:Seladelpar

Contact Research Centre

Alpha-1 antitrypsin deficiency

Recruiting

Registered drug

Study on Fazirsiran for Patients with Alpha-1 Antitrypsin Deficiency Liver Disease and Mild Fibrosis

Registered drug

Poland

Participants:18–64 years · 65+ years
Substances:Fazirsiran

Contact Research Centre

Prostate cancer metastatic

Recruiting

Registered drugNo placebo

Study on Long-Term Safety of Enzalutamide, Abiraterone, and Prednisolone for Patients with Prostate Cancer from Previous Enzalutamide Trials

Registered drugNo placebo

Poland

Participants:18–64 years · 65+ years
Substances:Abiraterone

Contact Research Centre

Find therapies in clinical trials near you

41 trials match your criteria

Metabolic dysfunction-associated steatohepatitis+1

A Phase III Study of Survodutide in Adults with Compensated NASH Cirrhosis to Assess Liver Outcomes and Safety

Metabolic dysfunction-associated steatohepatitis+1

A Phase III trial of BI 456906 weekly injections in adults with NASH and stage 2‑3 liver fibrosis

Metabolic dysfunction-associated liver disease

Study on the Effects of Pegozafermin for Patients with Nonalcoholic Steatohepatitis (NASH) and Fibrosis

Hepatic cirrhosis

Study of Pegozafermin Treatment for Patients with Liver Cirrhosis due to Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Cholangitis sclerosing

A Phase III Study of Elafibranor in Adults with Primary Sclerosing Cholangitis to Assess Efficacy and Safety

Metabolic dysfunction-associated steatohepatitis

A Phase 3 Study of Efimosfermin Alfa to Assess Safety and Tolerability in Adults with F2‑F3 Stage Metabolic Dysfunction‑Associated Steatohepatitis (MASH)

Metabolic dysfunction-associated steatohepatitis

Safety and Efficacy of Efimosfermin Alfa in Participants with Biopsy‑Confirmed F2‑ or F3‑Stage Metabolic Dysfunction‑Associated Steatohepatitis (MASH)

Metabolic dysfunction-associated liver disease

Prostate cancer

A study testing ASP5541 compared to abiraterone acetate in patients with advanced prostate cancer

Primary biliary cholangitis

Study of Seladelpar Treatment in Patients with Primary Biliary Cholangitis and Compensated Cirrhosis

Alpha-1 antitrypsin deficiency

Study on Fazirsiran for Patients with Alpha-1 Antitrypsin Deficiency Liver Disease and Mild Fibrosis

Prostate cancer metastatic

Study on Long-Term Safety of Enzalutamide, Abiraterone, and Prednisolone for Patients with Prostate Cancer from Previous Enzalutamide Trials

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.